Market Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Reconnecting…
Home/IPO/Himalaya Nutravedics IPO
Updated: 29-Sep 9:33
Himalaya Nutravedics

Himalaya Nutravedics IPO

ListedBSE SME

Listing at: BSE SME • Plot No. 101/A, Phase-IIIIndustrial Development ParkCherlapally, Hindustan Cables Ltd, UppalHyderabad, Telangana, 500051

Allotment status Allotment is outDeclared 27 Sept 2026
Check

Disclaimer: GMP values change dynamically. This data is strictly for educational purposes only and not an investment advice.

Live GMP Today
₹0 (0%)
Rating:1/5
Est. Listing Price
₹106
Est. Gain: –
Est. Profit / Lot
₹0
Per Retail Application
Price Band
₹106
Face Value: ₹10
Min. Retail Inv.
₹1,27,200
Lot: 1200 Shares
Total Subscription
2.33x
Anchor: Yes

Himalaya Nutravedics IPO GMP History

Genuine daily snapshots retained by the WeeStox backend

Disclaimer: GMP values change dynamically. This data is strictly for educational purposes only and not an investment advice.

GMP dateIPO priceGMPPremiumEst. profit / lotSubscriptionMovement
30 Sept 2026₹106₹00.00%+₹02.33xFlat
29 Sept 2026₹106₹00.00%+₹02.33xFlat
28 Sept 2026₹106₹00.00%+₹02.33xFlat
27 Sept 2026₹106₹00.00%+₹02.33xFlat
26 Sept 2026₹106₹00.00%+₹02.33xFlat
25 Sept 2026₹106₹00.00%+₹02.33xFlat
24 Sept 2026₹106₹00.00%+₹02.33xFlat

Explore the complete GMP movement

Open the chart and all available daily records.

Himalaya Nutravedics IPO Details

IPO Date22 Sept 2026 to 24 Sept 2026
Listing AtBSE SME
Face Value₹10 per share
Price Band₹106
Lot Size1200 Shares
Total Issue Size₹26.50 Cr(₹1,255.57 Cr)
Fresh Issue25.00L shares (₹25 Cr)
Offer for Sale (OFS)Nil
Issue TypeSME Issue

Himalaya Nutravedics IPO Timetable

IPO Open Date22 Sept 2026
IPO Close Date24 Sept 2026
Basis of Allotment25 Sept 2026
Initiation of Refunds28 Sept 2026
Credit of Shares to Demat28 Sept 2026
Listing Date29 Sept 2026
Cut-off time for UPI Mandate5 PM on 24 Sept 2026
Employee Discount₹20.00/share (Up to 52,083 shares)

Himalaya Nutravedics IPO Reservation

CategoryReservationShares Offered
QIB Shares Offered49.90%11,84,400
− Anchor Investor Shares Offered–7,10,400
− QIB (Ex. Anchor) Shares Offered–4,74,000
NII (HNI) Shares Offered15.02%3,56,400
− bNII > ₹10L Shares Offered–2,37,600
− sNII < ₹10L Shares Offered–1,18,800
Retail Shares Offered35.09%8,32,800
Market Maker Shares Offered–1,26,000

Himalaya Nutravedics Anchor Details

PDF
Anchor Bid Date21 Sept 2026
Anchor Shares Offered7,10,400 Shares
Total Anchor Portion₹7.53 Cr
Lock-in 50% End Date25 Oct 2026 (30 Days)
Lock-in Rem. 50% Date24 Dec 2026 (90 Days)

Himalaya Nutravedics IPO Lot Size

ApplicationLotsSharesAmount (Cut-off)Reserved Applications
Individual investors (IND) (Min)2 Lots Shares₹2,54,400–
Individual investors (IND) (Max)2 Lots Shares₹2,54,400–
S-HNI (Min)3 Lots Shares₹3,81,600–
S-HNI (Max)7 Lots Shares₹8,90,400–
B-HNI (Min)8 Lots Shares₹10,17,600–

Himalaya Nutravedics Promoter Holding

Pre-Issue HoldingDisclosed in RHP
Post-Issue HoldingTo be calculated

Himalaya Nutravedics IPO Live Subscription Status

Bidding demand breakdown by shares, institutional demand in ₹ Cr, applications & HNI funding cost
Overall Demand:2.33x
06:15 pm
Investor CategoryShares OfferedShares BiddedSubscription Times
QIBs4,74,000–0.00x
HNIs3,56,4001,75,2000.49x
bHNI2,37,6001,11,6000.47x
sHNI1,18,80063,6000.54x
Individual8,32,8005,54,4000.67x
Total16,63,2007,29,6000.44x

Himalaya Nutravedics Limited Financial Information (Restated Consolidated in ₹ Crores)

Period EndedAssetsTotal IncomeProfit After TaxEBITDANet WorthTotal Borrowing
31 Mar 2026₹24.42 Cr₹43.12 Cr₹7.39 Cr₹8.10 Cr₹16.38 Cr₹5.13 Cr
30 Mar 2026₹24.42 Cr₹43.12 Cr₹7.39 Cr₹8.10 Cr₹16.38 Cr₹5.13 Cr
31 Mar 2025₹10.82 Cr₹21.00 Cr₹2.23 Cr₹2.99 Cr₹6.75 Cr₹1.76 Cr
30 Mar 2025₹10.82 Cr₹21.00 Cr₹2.23 Cr₹2.99 Cr₹6.75 Cr₹1.76 Cr
31 Mar 2024₹6.09 Cr₹14.43 Cr₹0.43 Cr₹0.94 Cr₹1.34 Cr₹3.24 Cr
30 Mar 2024₹6.09 Cr₹14.43 Cr₹0.43 Cr₹0.94 Cr₹1.34 Cr₹3.24 Cr

Himalaya Nutravedics Key Valuation & Financial KPIs

ROE63.87%
ROCE36.41%
Debt / Equity0.31x
P/E (Post IPO)12.63
EBITDA Margin18.82%
Market Cap₹93.3 Cr

Himalaya Nutravedics IPO Analysis

Review the company's key advantages and material business risks.

10 Strengths

Strengths & Positives

Competitive advantages and operational merits

  • Incorporated in June 2022, Himalaya Nutravedics India Limited is a Hyderabad-based Ayurvedic and nutraceutical manufacturing company engaged in the formulation, manufacturing and marketing of Ayurvedic and nutraceutical products. Its portfolio includes softgel capsules, tablets, medicated oils, liquid orals, hardgel capsules and protein powders across categories such as digestive health, immunity, metabolic health and pain management.

  • The company markets its branded products through healthcare practitioners and also undertakes third-party contract manufacturing. It has expanded its presence across 17 states and one union territory in India.

  • Himalaya Nutravedics operates a manufacturing facility in Hyderabad, Telangana, which holds ISO 22000:2018, ISO 9001:2015 and WHO-GMP certifications. These certifications support its manufacturing and quality-control processes.

  • The company has developed integrated capabilities across multiple dosage forms, allowing it to manufacture a diverse range of Ayurvedic and nutraceutical products. As of April 30, 2026, it had 80 employees.

  • Integrated Multi-Dosage Manufacturing: The company has manufacturing capabilities across multiple dosage forms, including capsules, tablets, oils, liquid orals and powders. This allows it to cater to diverse product requirements across therapeutic categories.

  • Doctor Acceptance: The company markets its branded products through healthcare practitioners, with doctor acceptance supported by product performance rather than mass advertising. This provides an established channel for its branded product portfolio.

  • Long-Standing Relationships:Himalaya Nutravedics has established relationships with its suppliers and customers. These relationships support the company's procurement and sales operations.

  • Dependence on Ayurvedic Products: Ayurvedic products accounted for 94.57%, 92.09% and 79.27% of revenue from operations in Fiscal 2026, 2025 and 2024, respectively. Any reduction in demand for these products could adversely affect the company's business and financial performance.

  • Customer Concentration: Revenue from the company's top 10 customers accounted for 81.24%, 86.97% and 84.19% of revenue from operations in Fiscal 2026, 2025 and 2024, respectively. Loss of relationships with key customers or delays or reductions in their orders could adversely affect the company's business, financial condition and cash flows.

  • Supplier Concentration: The company has historically derived, and may continue to derive, a significant portion of its supplies from its top 10 suppliers. Any disruption in these supplier relationships could affect the availability and procurement of required raw materials and other supplies.

About Himalaya Nutravedics Limited

Himalaya Nutravedics IPO is a book build issue of ₹26.50 crores. The issue is entirely a fresh issue of 25.00 lakh shares of ₹26.50 crore.Himalaya Nutravedics IPO bidding opened for subscription on Sep 22, 2026 and will close on Sep 24, 2026. The allotment for the Himalaya Nutravedics IPO is expected to be finalized on Sep 25, 2026. Himalaya Nutravedics IPO will list on the BSE SME with a tentative listing date fixed as Sep 29, 2026.Himalaya Nutravedics IPO is set issue price band at ₹100 to ₹106 per share. The lot size for an application is 1,200 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,54,400 (2,400 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,600 shares), amounting to ₹3,81,600.Nirbhay Capital Services Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Allwin Securities Ltd.Refer to Himalaya Nutravedics IPO RHP for detailed Information.

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing and distribution of Ayurvedic and nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies. The Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements. Its products are available in multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, liquid orals and medicated oils. The products cater to therapeutic and wellness areas such as gut health, cardiac and metabolic wellness, diabetes management, pain management, immunity, women’s wellness and general wellness. Himalaya Nutravedics operates through a hybrid business model comprising its own branded products and third-party contract manufacturing. Under its own-brand business, the Company develops, manufactures and markets Ayurvedic and nutraceutical products, while its third-party manufacturing business provides formulation, manufacturing, packaging and dispatch services based on client specifications. As of March 31, 2026, its own-brand business contributed approximately ₹2,202.54 lakh, representing about 51.14% of total revenue. The Company operates an integrated manufacturing facility in Hyderabad, Telangana, where formulation, production, quality control, packaging and finished-goods release are carried out internally. The facility is compliant with WHO-GMP standards and holds registrations and licences from AYUSH and FSSAI, along with certifications including ISO 9001:2015, ISO 22000:2018, HACCP, HALAL and KOSHER. As of July 31, 2026, the Company had 86 full-time employees across marketing, factory, finance, quality, compliance and administration functions. • Geographic expansion across India. • Long-standing supplier and customer relationships. • Integrated multi-dosage manufacturing capabilities. • Doctor acceptance supported by product performance. • Broad therapeutic coverage across Ayurvedic and nutraceutical segments

Shariah Compliance Screening (AAOIFI Standard 21)

Business ActivityRequires ReviewImpermissible Revenue ≤ 5%
Debt-to-Assets Ratio21.01%Threshold ≤ 33% of Assets
Purification GuidanceStandard 0.5%Donate interest dividend fraction
Auditor Notes: Sector information not available — cannot screen business activity

Himalaya Nutravedics IPO Documents & Reports

Official prospectus, reports and regulatory filings
Document TitleAuthority / HostStatusAction
Red Herring Prospectus (RHP)
Complete offer document filed with ROC & SEBI
SEBI / ROCAvailable View RHP
Draft Red Herring Prospectus (DRHP)
Initial regulatory draft submitted for public comments
SEBI FilingsFiled View DRHP
Anchor Investor Allocation Report
Allotment list to institutional bidders
BSE / NSE CircularDisclosed Anchor PDF
IPO Allotment Status & Basis of Allotment
Registrar query portal via PAN / Application No.
Kfin TechnologiesLive Portal Check Allotment
Corporate Website & Investor Relations
Official portal and financial reports
Issuer PortalActive Visit Portal

Himalaya Nutravedics IPO Registrar & Lead Managers

Registrar of the Issue
Kfin Technologies
040-79615565
Book Running Lead Managers (BRLM)
  • Nirbhay Capital Services Pvt.Ltd.
Registered Office

Plot No. 101/A, Phase-IIIIndustrial Development ParkCherlapally, Hindustan Cables Ltd, UppalHyderabad, Telangana, 500051